Insulet | PODD - Ordinary Share Capital


Insulet reported $70.35M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Align Technology USD 71.75M 736K Dec/2025
AtriCure USD 49.7M 10K Sep/2025
Avanos Medical USD 46.42M 102.94K Sep/2025
Baxter International USD 514.28M 168.72M Dec/2025
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 1.46B Jun/2025
Cardinal Health USD 238M 1000K Sep/2025
Cooper Companies USD 198.81M 9K Sep/2025
Dexcom USD 384.8M 5.2M Dec/2025
Edwards Lifesciences USD 580.7M 7.2M Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Globus Medical USD 135.05M 134.92M Jun/2025
ICU Medical USD 24.69M 2K Dec/2025
Inogen USD 23K 0 Dec/2023
Insulet USD 70.35M 1000 Dec/2025
Integra LifeSciences USD 77.92M 77M Jun/2025
J&J USD 2.41B 584K Sep/2025
Masimo USD 53.1M 1.2M Sep/2025
Medtronic USD 1.28B 116K Sep/2025
Merit Medical Systems USD 59.29M 72K Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Solventum Corp USD 173.44M 52.16K Sep/2025
Stryker USD 382.4M 93K Dec/2025
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.19M 482K Jun/2025
West Pharmaceutical Services USD 72M 100K Dec/2025
Zimmer Biomet Holdings USD 198.18M 18.44K Dec/2025